Safety and Efficacy of adding pegylated Interferon–α2b to standard Dose Dasatinib in newly diagnosed CP-CML

Henrik Hjort-Hansen, Jepser Stentoft, Johan Richter, Perttu Koskenvesa, Stina Söderlund, Arta Dreimane, Kimmo Porkka, Tobias Gedde Dahl, Bjørn Tore Gjertsen, Franz X Gruber, Leif Stenke, Kristina Myhr Eriksson, Berit Markevärn, Hanne Vestergaard, Lene Udby, Ole Weis Bjerrum, Satu Mustjoki, Ulla Olsson-Strömberg

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

57 Downloads (Pure)
Original languageEnglish
Publication date2015
Publication statusPublished - 2015
Event57th American Society of Hematology Annual Meeting and Exposition - Orlando, United States
Duration: 4. Dec 20158. Dec 2015

Conference

Conference57th American Society of Hematology Annual Meeting and Exposition
Country/TerritoryUnited States
CityOrlando
Period04/12/201508/12/2015

Cite this